34916904|t|The Influence of MTHFR Polymorphism on Gray Matter Volume in Patients With Amnestic Mild Cognitive Impairment.
34916904|a|The methylenetetrahydrofolate reductase (MTHFR) gene has been associated with Alzheimer's disease (AD) pathogenesis. Amnestic mild cognitive impairment (aMCI) represents a prodromal stage of dementia and involves a high risk of progression into AD. Although the effects of the apolipoprotein E (APOE) gene on structural alterations in aMCI have been widely investigated, the effects of MTHFR C677T and interaction effects of MTHFR x APOE genotypes on gray matter atrophy in aMCI remain largely unknown. In the present study, 60 aMCI patients and 30 healthy controls were enrolled, and voxel-based morphometry analysis was performed to inspect the effects of diagnosis, different genotypes, and their interactions on gray matter atrophy. The results showed that aMCI patients had significant gray matter atrophy involving the bilateral hippocampus, the right parahippocampal gyrus, and the left superior temporal gyrus compared with healthy controls. Besides, a substantial reduction in gray matter volume was observed in the right hippocampus region in APOE epsilon4 carriers from the aMCI group, compared with APOE epsilon4 non-carriers. A significant interaction was found between diagnosis and MTHFR C677T genotype on the right precuneus in healthy controls and aMCI patients not carrying APOE epsilon4 allele. Our findings may provide new evidence substantiating the genetic effects of MTHFR C677T on brain structural alternation in patients with aMCI.
34916904	17	22	MTHFR	Gene	4524
34916904	61	69	Patients	Species	9606
34916904	84	109	Mild Cognitive Impairment	Disease	MESH:D060825
34916904	115	150	methylenetetrahydrofolate reductase	Gene	4524
34916904	152	157	MTHFR	Gene	4524
34916904	189	208	Alzheimer's disease	Disease	MESH:D000544
34916904	210	212	AD	Disease	MESH:D000544
34916904	237	262	mild cognitive impairment	Disease	MESH:D060825
34916904	264	268	aMCI	Disease	MESH:D060825
34916904	302	310	dementia	Disease	MESH:D003704
34916904	356	358	AD	Disease	MESH:D000544
34916904	388	404	apolipoprotein E	Gene	348
34916904	406	410	APOE	Gene	348
34916904	446	450	aMCI	Disease	MESH:D060825
34916904	497	502	MTHFR	Gene	4524
34916904	503	508	C677T	DNAMutation	tmVar:c|SUB|C|677|T;HGVS:c.677C>T;VariantGroup:0;CorrespondingGene:4524;RS#:1801133;CorrespondingSpecies:9606;CA#:170990
34916904	536	541	MTHFR	Gene	4524
34916904	544	548	APOE	Gene	348
34916904	562	581	gray matter atrophy	Disease	MESH:D002549
34916904	585	589	aMCI	Disease	MESH:D060825
34916904	639	643	aMCI	Disease	MESH:D060825
34916904	644	652	patients	Species	9606
34916904	827	846	gray matter atrophy	Disease	MESH:D002549
34916904	872	876	aMCI	Disease	MESH:D060825
34916904	877	885	patients	Species	9606
34916904	902	921	gray matter atrophy	Disease	MESH:D002549
34916904	1164	1168	APOE	Gene	348
34916904	1196	1200	aMCI	Disease	MESH:D060825
34916904	1222	1226	APOE	Gene	348
34916904	1308	1313	MTHFR	Gene	4524
34916904	1314	1319	C677T	DNAMutation	tmVar:c|SUB|C|677|T;HGVS:c.677C>T;VariantGroup:0;CorrespondingGene:4524;RS#:1801133;CorrespondingSpecies:9606;CA#:170990
34916904	1376	1380	aMCI	Disease	MESH:D060825
34916904	1381	1389	patients	Species	9606
34916904	1403	1407	APOE	Gene	348
34916904	1501	1506	MTHFR	Gene	4524
34916904	1507	1512	C677T	DNAMutation	tmVar:c|SUB|C|677|T;HGVS:c.677C>T;VariantGroup:0;CorrespondingGene:4524;RS#:1801133;CorrespondingSpecies:9606;CA#:170990
34916904	1548	1556	patients	Species	9606
34916904	1562	1566	aMCI	Disease	MESH:D060825
34916904	Association	MESH:D060825	4524
34916904	Association	MESH:D002549	4524
34916904	Association	RS#:1801133;HGVS:c.677C>T;CorrespondingGene:4524	MESH:D060825
34916904	Association	MESH:D000544	4524
34916904	Association	MESH:D060825	348
34916904	Association	MESH:D002549	348
34916904	Association	MESH:D060825	4524

